D-0305-2021 Class II Terminated

Recalled by Sagent Pharmaceuticals Inc — Schaumburg, IL

Recall Details

Product Type
Drugs
Report Date
March 24, 2021
Initiation Date
March 11, 2021
Termination Date
December 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3716 cartons

Product Description

Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.

Reason for Recall

Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Code Information

Lots: PHT8IB2, PHT9IB2, exp 08/2022; PHT1JB2, exp 09/2022